Scandion Oncology (Sweden) Analysis
| SCOL Stock | SEK 0.02 0 5.41% |
Scandion Oncology AS is fairly valued with Real Value of 0.0168 and Hype Value of 0.02. The main objective of Scandion Oncology stock analysis is to determine its intrinsic value, which is an estimate of what Scandion Oncology AS is worth, separate from its market price. There are two main types of Scandion Oncology's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Scandion Oncology's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Scandion Oncology's stock to identify patterns and trends that may indicate its future price movements.
The Scandion Oncology stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Scandion Oncology is usually not traded on All Saints ' Day, St . John 's Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay. Scandion Stock trading window is adjusted to Europe/Stockholm timezone.
Scandion |
Scandion Stock Analysis Notes
The company has price-to-book ratio of 1.01. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Scandion Oncology recorded a loss per share of 1.74. The entity had not issued any dividends in recent years. Scandion Oncology AS, a biotechnology company, develops drugs for the treatment of chemotherapy resistance in cancer patients. The company was founded in 2017 and is based in Copenhagen, Denmark. Scandion Oncology operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people. To find out more about Scandion Oncology AS contact Johnny MS at 45 38 10 20 17 or learn more at https://www.scandiononcology.com.Scandion Oncology Investment Alerts
| Scandion Oncology generated a negative expected return over the last 90 days | |
| Scandion Oncology has high historical volatility and very poor performance | |
| Scandion Oncology has some characteristics of a very speculative penny stock | |
| Scandion Oncology has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (51.7 M) with loss before overhead, payroll, taxes, and interest of (32.32 M). | |
| Scandion Oncology AS has accumulated about 131.54 M in cash with (49.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Scandion Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 111.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Scandion Oncology's market, we take the total number of its shares issued and multiply it by Scandion Oncology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 16th of March 2025, Scandion Oncology has the Risk Adjusted Performance of (0.02), coefficient of variation of (2,586), and Variance of 436.5. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scandion Oncology, as well as the relationship between them.Scandion Oncology Price Movement Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Scandion Oncology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Scandion Oncology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Scandion Oncology Outstanding Bonds
Scandion Oncology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Scandion Oncology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Scandion bonds can be classified according to their maturity, which is the date when Scandion Oncology AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Scandion Oncology Predictive Daily Indicators
Scandion Oncology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Scandion Oncology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Scandion Oncology Forecast Models
Scandion Oncology's time-series forecasting models are one of many Scandion Oncology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Scandion Oncology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Scandion Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Scandion Oncology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Scandion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Scandion Oncology. By using and applying Scandion Stock analysis, traders can create a robust methodology for identifying Scandion entry and exit points for their positions.
Scandion Oncology AS, a biotechnology company, develops drugs for the treatment of chemotherapy resistance in cancer patients. The company was founded in 2017 and is based in Copenhagen, Denmark. Scandion Oncology operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Scandion Oncology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Additional Tools for Scandion Stock Analysis
When running Scandion Oncology's price analysis, check to measure Scandion Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandion Oncology is operating at the current time. Most of Scandion Oncology's value examination focuses on studying past and present price action to predict the probability of Scandion Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandion Oncology's price. Additionally, you may evaluate how the addition of Scandion Oncology to your portfolios can decrease your overall portfolio volatility.